IBI3030 significantly reduces LDL-c (p<0.01 vs. baseline) and Lp(a), improves oral glucose tolerance (OGTT) (effective even in GLP-1R knockout mice), reduces body weight, and preserves insulin ...

Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, investigator says.

On May 30, 2025, the United States Trotting Association (USTA), following an investigation by the Standardbred Racing ...

When an impressive opening act at the professional level and strong performances at the U23 camp string together, a first ...

CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...

A protocol designed for primary care increased weight loss across a quarter of a million people, but only 25% of those with a ...

The first diabetes and obesity pill that is similar to Ozempic — but in tablet form — may actually outperform the popular ...

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

An intervention designed to emphasize management of overweight and obesity in primary care settings was associated with ...

If you're looking for something a little more affordable, Anker's Sport X20 earbuds (black) can be had for $63.99 at Amazon (20% off) right now. Anker is best known for its mobile accessories ...